Published March 8, 2023 | Version 0.1

Molecular and functional properties of human Plasmodium falciparum CSP C-terminus antibodies

Contributors

  • 1. German Cancer Research Center (DKFZ), Heidelberg, DE

Description

AIRR Community-compliant information comprising all antibodies described in EMBO Mol Med 15:e17454 [DOI:10.15252/emmm.202317454].

Notes

The work was supported by the Bill and Melinda Gates Foundation (OPP1179906; J.P.J, H.W. and E.A.L.), by the CIFAR Azrieli Global Scholar program (J.P.J.), the Ontario Early Researcher Award program (J.P.J.), and the Canada Research Chair program (J.P.J.). C.B.A was supported by a by Hospital for Sick Children Restracomp Postdoctoral Fellowship and a Banting Postdoctoral Fellowship. X-ray diffraction experiments were performed at GM/CA@APS, which has been funded in whole or in part with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). The Eiger 16 M detector at GM/CA-XSD was funded by NIH grant S10 OD012289. This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science user facility operated for the DOE Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. Manufacture of PfSPZ Vaccine was funded in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under SBIR award numbers 5R44AI058375 and 5R44AI055229.

Files

Files (158.4 kB)

Name Size Download all
md5:e8735ec47134e32adf6525c12ff058af
60.7 kB Download
md5:ca644b5d15aa9840404720eab5f3c685
97.7 kB Download

Additional details

Related works

Is supplement to
Journal article: 10.15252/emmm.202317454 (DOI)